Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Active & Responsive
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
for
High-Risk Neuroblastoma
Location: Dallas TX, Aurora CO, Chicago IL, Minneapolis MN,
Sponsor: Renaissance Pharma Ltd.
Sex: All
Age: 1 - 18
Code: NCT07549321
Phase 2, Phase 3, Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: Dallas TX, Lawrence KS, Atlanta GA, Chicago IL,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase 1, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: Dallas TX, Overland Park KS, Downey CA, Elkins Park PA
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Dallas TX, Houston TX, Nashville TN, Chicago IL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 4+
Code: NCT06971731
Phase 3, Recruiting
Active & Responsive
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Dallas TX, Birmingham AL, Indianapolis IN,
Sponsor: Girish Dhall, MD
Sex: All
Age: 16+
Code: NCT06502171
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Location: Dallas TX, Houston TX, Little Rock AR, Phoenix AZ,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase 2, Recruiting
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: Dallas TX, Memphis TN, Kansas City MO, El Paso TX,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06850038
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
for
Niemann-Pick Type C Disease
Location: Dallas TX, Rochester MN, Minneapolis MN, Fairfax VA,